Society of Hematologic Oncology Insider news

Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer

15 min · 7. maj 2026
Billede af episoden Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer

Beskrivelse

In this SOHO Insider podcast, host Megan Melody, MD, from Tampa General Hospital, spoke with Nirav Shah, MD, professor at the Medical College of Wisconsin, on news from the 2026 Tandem Meetings, including updates on dual-targeted CAR T-cell results in CLL and interim phase 2 data on zamtocabtagene autoleucel (zamto-cel) in in transplant-ineligible patients with DLBCL. Of dual-targeting CAR-T cell therapies, he said, “I think this is the next iteration in CAR. Zamtocabtagene is one of four 20/19 CARs under development and if you look at the data for all of them, they look to be highly efficacious, better than our standard CD19-CAR.” Listen to more podcasts on sohoinsider.com.  [https://sohoinsider.com/category/soho-insider-podcast/]

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af Society of Hematologic Oncology Insider news-fællesskabet!

Kom i gang

1 måned kun 9 kr.

Derefter 99 kr. / måned · Opsig når som helst

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

15 episoder

Billede af episoden Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer

Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer

In this SOHO Insider podcast, host Megan Melody, MD, from Tampa General Hospital, spoke with Nirav Shah, MD, professor at the Medical College of Wisconsin, on news from the 2026 Tandem Meetings, including updates on dual-targeted CAR T-cell results in CLL and interim phase 2 data on zamtocabtagene autoleucel (zamto-cel) in in transplant-ineligible patients with DLBCL. Of dual-targeting CAR-T cell therapies, he said, “I think this is the next iteration in CAR. Zamtocabtagene is one of four 20/19 CARs under development and if you look at the data for all of them, they look to be highly efficacious, better than our standard CD19-CAR.” Listen to more podcasts on sohoinsider.com.  [https://sohoinsider.com/category/soho-insider-podcast/]

7. maj 202615 min
Billede af episoden Why clinicians should lead hospitals, according to Prof. Amanda Goodall

Why clinicians should lead hospitals, according to Prof. Amanda Goodall

Prof. Amanda Goodall, director of the Executive Master’s in Medical Leadership (EMML), a specialized MSc degree from Bayes Business School offering advanced leadership training to medical doctors, joined SOHO Insider podcast host Prof. Christopher Fox, a professor of hematology at Nottingham University Hospitals NHS Trust, for a discussion on expert leadership in healthcare. According to Prof. Goodall, expert leadership is the idea that organizations perform best when leaders are experts in the core work of the institution. As part of this work, she runs an executive master’s program in medical leadership, designed to help physicians develop the skills needed to lead healthcare organizations while maintaining credibility as clinicians. Her research argues that in healthcare this means placing experienced, high-performing physicians in leadership roles rather than relying primarily on generalist managers. Many doctors, she noted, are interested in leadership because they want to drive meaningful change and improve patient care, but historically they have had limited access to formal leadership training. The podcast was taped during the inaugural meeting of SOHO UK [https://sohoinsider.com/category/meetings-conferences/soho-uk/], where Prof. Goodall gave a talk after dinner on the topic. Learn about the Executive Master’s in Medical Leadership (EMML) program [https://www.bayes.citystgeorges.ac.uk/study/degree-apprenticeships/executive-msc-in-medical-leadership].

10. mar. 20266 min